伊犁川宁生物技术股份有限公司 2025年第三季度报告

Core Points - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any misrepresentation or omissions [2][3][4] Financial Data - The third-quarter financial report has not been audited [7] - The company does not require retrospective adjustments or restatements of previous accounting data [3] - There are no non-recurring profit and loss items applicable for the reporting period [3][4] Major Changes in Financial Indicators - The report indicates significant changes in the consolidated balance sheet, income statement, and cash flow statement, but specific figures and reasons for these changes are not provided [4][5] Shareholder Information - The report includes details on the total number of common shareholders and the top ten shareholders, but specific data is not disclosed [5] Other Important Matters - The company completed the issuance of the first phase of technology innovation bonds for rural revitalization, with a total issuance scale of 200 million yuan, a price of 100 yuan per bond, a term of 185 days, and a coupon rate of 1.99% [5]